These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 10807673)

  • 1. Troglitazone prevents and reverses dexamethasone induced insulin resistance on glycogen synthesis in 3T3 adipocytes.
    Anil Kumar KL; Marita AR
    Br J Pharmacol; 2000 May; 130(2):351-8. PubMed ID: 10807673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of vanadate on glycogen synthesis in dexamethasone-treated 3T3 adipocytes: evidence for a novel insulin sensitizing action.
    Marita AR; Anilkumar KL
    Diabetes Obes Metab; 2001 Aug; 3(4):271-8. PubMed ID: 11520307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Troglitazone enhances differentiation, basal glucose uptake, and Glut1 protein levels in 3T3-L1 adipocytes.
    Tafuri SR
    Endocrinology; 1996 Nov; 137(11):4706-12. PubMed ID: 8895337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Troglitazone antagonizes metabolic effects of glucocorticoids in humans: effects on glucose tolerance, insulin sensitivity, suppression of free fatty acids, and leptin.
    Willi SM; Kennedy A; Wallace P; Ganaway E; Rogers NL; Garvey WT
    Diabetes; 2002 Oct; 51(10):2895-902. PubMed ID: 12351424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Troglitazone increases system A amino acid transport in 3T3-L1 cells.
    Su TZ; Wang M; Oxender DL; Saltiel AR
    Endocrinology; 1998 Mar; 139(3):832-7. PubMed ID: 9492010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concentration-dependent stimulatory and inhibitory effect of troglitazone on insulin-induced fatty acid synthase expression and protein kinase B activity in 3T3-L1 adipocytes.
    Barthel A; Krüger KD; Roth RA; Joost HG
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Apr; 365(4):290-5. PubMed ID: 11919653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of troglitazone on dexamethasone-induced insulin resistance in rats.
    Okumura S; Takeda N; Takami K; Yoshino K; Hattori J; Nakashima K; Sugimoto M; Ishimori M; Takami R; Yasuda K
    Metabolism; 1998 Mar; 47(3):351-4. PubMed ID: 9500576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humoral regulation of resistin expression in 3T3-L1 and mouse adipose cells.
    Shojima N; Sakoda H; Ogihara T; Fujishiro M; Katagiri H; Anai M; Onishi Y; Ono H; Inukai K; Abe M; Fukushima Y; Kikuchi M; Oka Y; Asano T
    Diabetes; 2002 Jun; 51(6):1737-44. PubMed ID: 12031960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thiazolidinediones exert different effects on insulin resistance between dexamethasone-treated rats and wistar fatty rats.
    Kimura M; Daimon M; Tominaga M; Manaka H; Sasaki H; Kato T
    Endocr J; 2000 Feb; 47(1):21-8. PubMed ID: 10811289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thiazolidinediones inhibit lipoprotein lipase activity in adipocytes.
    Ranganathan S; Kern PA
    J Biol Chem; 1998 Oct; 273(40):26117-22. PubMed ID: 9748292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of troglitazone on leptin production. Studies in vitro and in human subjects.
    Nolan JJ; Olefsky JM; Nyce MR; Considine RV; Caro JF
    Diabetes; 1996 Sep; 45(9):1276-8. PubMed ID: 8772734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of troglitazone on cellular differentiation, insulin signaling, and glucose metabolism in cultured human skeletal muscle cells.
    Kausch C; Krützfeldt J; Witke A; Rettig A; Bachmann O; Rett K; Matthaei S; Machicao F; Häring HU; Stumvoll M
    Biochem Biophys Res Commun; 2001 Jan; 280(3):664-74. PubMed ID: 11162573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined effects of troglitazone and muscle contraction on insulin sensitization in Balb-c mouse muscle.
    Vander Lugt JT; Gómez-Márquez J; Caldon J; Louters LL
    Biochimie; 2001 May; 83(5):445-51. PubMed ID: 11368854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bis(alpha-furancarboxylato)oxovanadium(IV) prevents and improves dexamethasone-induced insulin resistance in 3T3-L1 adipocytes.
    Zuo YQ; Liu WP; Niu YF; Tian CF; Xie MJ; Chen XZ; Li L
    J Pharm Pharmacol; 2008 Oct; 60(10):1335-40. PubMed ID: 18812026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paradoxical effect of troglitazone in normal animals: enhancement of adipocyte but reduction of liver insulin sensitivity.
    Dea MK; Van Citters GW; Ader M; Mittelman SD; Sunehag AL; Bergman RN
    Diabetes; 2000 Dec; 49(12):2087-93. PubMed ID: 11118011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Troglitazone regulation of glucose metabolism in human skeletal muscle cultures from obese type II diabetic subjects.
    Park KS; Ciaraldi TP; Abrams-Carter L; Mudaliar S; Nikoulina SE; Henry RR
    J Clin Endocrinol Metab; 1998 May; 83(5):1636-43. PubMed ID: 9589670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thiazolidinediones attenuate lipolysis and ameliorate dexamethasone-induced insulin resistance.
    He J; Xu C; Kuang J; Liu Q; Jiang H; Mo L; Geng B; Xu G
    Metabolism; 2015 Jul; 64(7):826-36. PubMed ID: 25825274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Troglitazone prevents the inhibitory effects of inflammatory cytokines on insulin-induced adipocyte differentiation in 3T3-L1 cells.
    Ohsumi J; Sakakibara S; Yamaguchi J; Miyadai K; Yoshioka S; Fujiwara T; Horikoshi H; Serizawa N
    Endocrinology; 1994 Nov; 135(5):2279-82. PubMed ID: 7956951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute effect of troglitazone on glucose metabolism in the absence or presence of insulin in perfused rat hindlimb.
    Okuno A; Ikeda K; Shiota M; Fujiwara T; Yoshioka S; Sugano T; Horikoshi H
    Metabolism; 1997 Jun; 46(6):716-21. PubMed ID: 9186311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Troglitazone treatment increases plasma vascular endothelial growth factor in diabetic patients and its mRNA in 3T3-L1 adipocytes.
    Emoto M; Anno T; Sato Y; Tanabe K; Okuya S; Tanizawa Y; Matsutani A; Oka Y
    Diabetes; 2001 May; 50(5):1166-70. PubMed ID: 11334422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.